publication . Article . Other literature type . 2017

Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options

Tanna Preena; Strauss Rupert W; Fujinami Kaoru; Michaelides Michel;
Open Access
  • Published: 01 Jan 2017 Journal: British Journal of Ophthalmology, volume 101, pages 25-30 (issn: 0007-1161, eissn: 1468-2079, Copyright policy)
  • Publisher: BMJ
  • Country: United Kingdom
Abstract
Stargardt disease (STGD1; MIM 248200) is the most prevalent inherited macular dystrophy and is associated with disease-causing sequence variants in the gene ABCA4 . Significant advances have been made over the last 10 years in our understanding of both the clinical and molecular features of STGD1, and also the underlying pathophysiology, which has culminated in ongoing and planned human clinical trials of novel therapies. The aims of this review are to describe the detailed phenotypic and genotypic characteristics of the disease, conventional and novel imaging findings, current knowledge of animal models and pathogenesis, and the multiple avenues of intervention...
Subjects
free text keywords: ABCA4, biology.protein, biology, Macular degeneration, medicine.disease, medicine, Clinical trial, Dystrophy, Molecular genetics, medicine.medical_specialty, Macular dystrophy, Pathology, business.industry, business, Disease, Stargardt disease, Dystrophy, Imaging, Retina, 1506, Review, Imaging, Retina
Funded by
FWF| Development of Efficacy Measures in Stargardt Mac. Dystrophy
Project
  • Funder: Austrian Science Fund (FWF) (FWF)
  • Project Code: J 3383
  • Funding stream: Schrödinger-Programm
,
WT| High Resolution Retinal Imaging.
Project
  • Funder: Wellcome Trust (WT)
  • Project Code: 099173
  • Funding stream: Neuroscience and Mental Health
79 references, page 1 of 6

1 Michaelides M, Hunt DM, Moore AT The genetics of inherited macular dystrophies. J Med Genet 2003;40:641–50. 10.1136/jmg.40.9.641 12960208 [OpenAIRE] [PubMed] [DOI]

2 Fujinami K, Lois N, Davidson AE, et al A longitudinal study of stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations. Am J Ophthalmol 2013;155:1075–88. 10.1016/j.ajo.2013.01.018 23499370 [OpenAIRE] [PubMed] [DOI]

3 Fujinami K, Zernant J, Cha na RK, et al Clinical and molecular characteristics of childhood-onset Stargardt disease. Ophthalmology 2015;122:326–34. 10.1016/j.ophtha.2014.08.012 25312043 [OpenAIRE] [PubMed] [DOI]

4 Molday RS Insights into the molecular properties of ABCA4 and its role in the visual cycle and stargardt disease. Prog Mol Biol Transl Sci 2015;134:415–31. 10.1016/bs.pmbts.2015.06.008 26310168 [OpenAIRE] [PubMed] [DOI]

5 Strauss RW, Ho A, Munoz B, et al The natural history of the progression of atrophy secondary to Stargardt disease (ProgStar) studies: design and baseline characteristics: ProgStar Report No. 1. Ophthalmology 2016;123:817–28. 10.1016/j.ophtha.2015.12.009 26786511 [OpenAIRE] [PubMed] [DOI]

6 Burke TR, Tsang SH Allelic and phenotypic heterogeneity in ABCA4 mutations. Ophthalmic Genet 2011;32:165–74. 10.3109/13816810.2011.565397 21510770 [OpenAIRE] [PubMed] [DOI]

7 Lambertus S, van Huet RA, Bax NM, et al Early-onset stargardt disease: phenotypic and genotypic characteristics. Ophthalmology 2015;122:335–44. 10.1016/j.ophtha.2014.08.032 25444351 [OpenAIRE] [PubMed] [DOI]

8 Allikmets R, Singh N, Sun H, et al A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997;15:236–46. 10.1038/ng0397-236 9054934 [OpenAIRE] [PubMed] [DOI]

9 Fujinami K, Zernant J, Chana RK, et al ABCA4 gene screening by next-generation sequencing in a British cohort. Invest Ophthalmol Vis Sci 2013;54:6662–74. 10.1167/iovs.13-12570 23982839 [OpenAIRE] [PubMed] [DOI]

10 Zernant J, Schubert C, Im KM, et al Analysis of the ABCA4 gene by next-generation sequencing. Invest Ophthalmol Vis Sci 2011;52:8479–87. 10.1167/iovs.11-8182 21911583 [OpenAIRE] [PubMed] [DOI]

11 Haji Abdollahi S, Hirose T Stargardt-Fundus flavimaculatus: recent advancements and treatment. Semin Ophthalmol 2013;28:372–6. 10.3109/08820538.2013.825286 24138045 [OpenAIRE] [PubMed] [DOI]

12 Michaelides M, Chen LL, Brantley MA Jr, et al ABCA4 mutations and discordant ABCA4 alleles in patients and siblings with bull's-eye maculopathy. Br J Ophthalmol 2007;91:1650–5. 10.1136/bjo.2007.118356 18024811 [OpenAIRE] [PubMed] [DOI]

13 Fujinami K, Lois N, Mukherjee R, et al A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations. Invest Ophthalmol Vis Sci 2013;54:8181–90. 10.1167/iovs.13-12104 24265018 [OpenAIRE] [PubMed] [DOI]

14 Fujinami K, Sergouniotis PI, Davidson AE, et al The clinical effect of homozygous ABCA4 alleles in 18 patients. Ophthalmolo gy 2013;120:2324–31. 10.1016/j.ophtha.2013.04.016 23769331 [OpenAIRE] [PubMed] [DOI]

15 Fujinami K, Sergouniotis PI, Davidson AE, et al Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function. Am J Ophthalmol 2013;156:487–501 e1. 10.1016/j.ajo.2013.05.003 23953153 [OpenAIRE] [PubMed] [DOI]

79 references, page 1 of 6
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . Other literature type . 2017

Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options

Tanna Preena; Strauss Rupert W; Fujinami Kaoru; Michaelides Michel;